Original article
Sjögren-Larsson syndrome: Inherited defect in the fatty alcohol cycle*

https://doi.org/10.1016/S0022-3476(89)80070-8Get rights and content

We investigated fatty alcohol metabolism in eight patients with Sjögren-Larsson syndrome, and in nine obligate heterozygotes. Fatty alcohol: nicotinamide-adenine dinucleotide oxidoreductase (FAO) activity was deficient in cultured skin fibroblasts (mean 18% of normal, n=8) and peripheral blood leukocytes (mean 22% of normal, n=3) from patients with Sjögren-Larsson syndrome. The palmitoyl coenzyme A-inhibitable component of FAO activity was decreased to 10% and 15% of normal in fibroblasts and leukocytes, respectively, of patients with Sjögren-Larsson syndrome. Most affected patients accumulated long-chain fatty alcohol in plasma, with a greater relative accumulation of octadecanol (mean threefold greater than normal) than hexadecanol (mean twofold greater than normal). Erythrocyte lipid alkyl ether linkages derived from hexadecanol were slightly increased in three of four patients. Fibroblasts and leukocytes from heterozygotes with Sjögren-Larsson syndrome showed mean FAO activities that were intermediate between those seen in homozygotes and in normal control subjects. The heterozygotes had normal fatty alcohol concentrations in plasma. These studies demonstrate FAO deficiency in patients with Sjögren-Larsson syndrome, and suggest that accumulation of fatty alcohol or its metabolic products may be important in the pathogenesis of this disorder.

References (22)

  • LeeT-C

    Characterization of fatty alcohol: NAD+ oxidoreductase from rat liver

    J Biol Chem

    (1979)
  • Cited by (66)

    • 1-O-Alkylglycerol accumulation reveals abnormal ether glycerolipid metabolism in Sjögren-Larsson syndrome

      2020, Molecular Genetics and Metabolism
      Citation Excerpt :

      The AGs were quantitated using C17:0-AG as internal standard and expressed as μg/ml plasma or packed RBCs. RBC lipid extracts were transmethylated with 1 M methanolic-HCl for determination of DMA composition by GC–MS [11]. Data were expressed as the ratio of 16:0-DMA and C18:0-DMA to their corresponding fatty acid methyl esters.

    • An examination of pentafluorobenzoyl derivatization strategies for the analysis of fatty alcohols using gas chromatography/electron capture negative ion chemical ionization-mass spectrometry

      2011, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
      Citation Excerpt :

      Plasma levels of FOH in biological samples are typically expressed as a percentage of total FOH. In humans, plasma FOH levels range from 10 to 400 ng/mL, with the higher levels observed in humans with Sjögren–Larsson syndrome [6,8]. For example, in unaffected humans 16:0- and 18:0-OH plasma levels are 10 and 7 ng/mL, respectively [6].

    • Enzymatic diagnosis of Sjögren-Larsson syndrome using electrospray ionization mass spectrometry

      2009, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
    • Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome

      2008, Journal of Lipid Research
      Citation Excerpt :

      Unlike the neutral lipids, convincing increases were not seen in the plasmalogen phospholipid levels in keratinocytes, as estimated by phospholipid DMA composition. Previous studies have shown that DMA levels in erythrocytes from SLS patients are either normal or mildly increased (21). FAO deficiency in SLS keratinocytes resulted in a large increase in fatty alcohol content similar to that seen in SLS fibroblasts.

    • Fatty aldehyde dehydrogenase: Genomic structure, expression and mutation analysis in Sjögren-Larsson syndrome

      2001, Chemico-Biological Interactions
      Citation Excerpt :

      The first insight into this role arose from finding abnormal fatty alcohol metabolism in patients’ cells [9,42]. Fatty alcohols that are 16- to 18-carbons long accumulate in cultured cells and plasma from SLS patients, which implicates FALDH in the oxidation of long-chain aliphatic alcohol to fatty acid [43–45]. This metabolic pathway is catalyzed by fatty alcohol:NAD+ oxidoreductase, a complex microsomal enzyme that requires fatty alcohol dehydrogenase along with FALDH as enzymatic components [46,47].

    View all citing articles on Scopus
    *

    Supported by Basil O'Connor Starter Research Grant No. 5-476, March of Dimes; National Institutes of Health grant No. DK33914, and a grant from the Medical College of Virginia Children's Miracle Network Telethon.

    View full text